August 26, 2020
Detection of Ebola virus illness epizootics.
Prolonged-term wildlife mortality surveillance in northern Congo: a model for the detection of Ebola virus sickness epizootics.
Ebolavirus (EBOV) has precipitated sickness outbreaks taking tons of of lives, costing billions of {{dollars}} in administration efforts and threatening good ape populations. EBOV ecology should not be completely understood nonetheless contaminated wildlife and consumption of animal carcasses have been linked to human outbreaks, notably inside the Congo Basin.
Partnering with the Congolese Ministry of Nicely being, we carried out wildlife mortality surveillance and educational outreach inside the northern Republic of Congo (RoC). Designed for EBOV detection and to alert public properly being authorities, we established a low-cost wildlife mortality reporting group masking 50 000 km2.
Concurrently, we delivered educational outreach promoting behavioural change to over 6600 people in rural northern RoC. We achieved specimen assortment by teaching enterprise employees on a protected sampling protocol and equipping geographically distributed bases with sampling kits.
We established in-country diagnostics for EBOV testing, reducing diagnostic turnaround time to a few days and demonstrated the absence of EBOV in 58 carcasses. Central Africa stays a high-risk EBOV space, nonetheless RoC, home to crucial remaining populations of good apes, has not had an epidemic since 2005.
This effort continues to function as an untested early warning system in RoC, the place people and good apes have died from earlier Ebola virus sickness outbreaks. This textual content is part of the theme topic ‘Dynamic and integrative approaches to understanding pathogen spillover’.
sebov-detection
PSMB8 antibody |
|||
| 22848-100ul | SAB | 100ul | EUR 390 |
PSMB8 Antibody |
|||
| 43134-100ul | SAB | 100ul | EUR 252 |
PSMB8 Antibody |
|||
| BF0434 | Affbiotech | 200ul | EUR 376 |
|
Description: PSMB8 antibody detects endogenous levels of total PSMB8. |
|||
PSMB8 antibody |
|||
| 70R-19589 | Fitzgerald | 50 ul | EUR 435 |
|
Description: Rabbit polyclonal PSMB8 antibody |
|||
PSMB8 antibody |
|||
| 70R-13550 | Fitzgerald | 100 ul | EUR 457 |
|
Description: Affinity purified Rabbit polyclonal PSMB8 antibody |
|||
Anti-PSMB8 antibody |
|||
| STJ29479 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
|||
Anti-PSMB8 antibody |
|||
| STJ11100809 | St John's Laboratory | 100 µl | EUR 413 |
|
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
|||
PSMB8 Conjugated Antibody |
|||
| C43134 | SAB | 100ul | EUR 397 |
Psmb8/ Rat Psmb8 ELISA Kit |
|||
| ELI-15652r | Lifescience Market | 96 Tests | EUR 886 |
PSMB8 siRNA |
|||
| 20-abx930156 | Abbexa |
|
|
PSMB8 siRNA |
|||
| 20-abx930157 | Abbexa |
|
|
PSMB8 siRNA |
|||
| 20-abx904317 | Abbexa |
|
|
pOTB7-PSMB8 |
|||
| PVT18497 | Lifescience Market | 2 ug | EUR 231 |
PSMB8 Antibody, HRP conjugated |
|||
| 1-CSB-PA018886LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
PSMB8 Antibody, FITC conjugated |
|||
| 1-CSB-PA018886LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
PSMB8 Antibody, Biotin conjugated |
|||
| 1-CSB-PA018886LD01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
PSMB8 Rabbit pAb |
|||
| A7340-100ul | Abclonal | 100 ul | EUR 308 |
PSMB8 Rabbit pAb |
|||
| A7340-200ul | Abclonal | 200 ul | EUR 459 |
PSMB8 Rabbit pAb |
|||
| A7340-20ul | Abclonal | 20 ul | EUR 183 |
PSMB8 Rabbit pAb |
|||
| A7340-50ul | Abclonal | 50 ul | EUR 223 |
PSMB8 Blocking Peptide |
|||
| BF0434-BP | Affbiotech | 1mg | EUR 195 |
anti-PSMB8 (1A5) |
|||
| LF-MA30618 | Abfrontier | 100 ul | EUR 527 |
|
Description: Mouse Monoclonal to PSMB8 |
|||
Anti-PSMB8 / LMP7 Monoclonal Antibody |
|||
| M02188-2 | BosterBio | 100ug | EUR 397 |
|
Description: Rabbit Monoclonal PSMB8 / LMP7 Antibody. Validated in IP, IF, WB and tested in Human, Mouse, Rat. |
|||
Monoclonal PSMB8 Antibody, Clone: 1A5 |
|||
| AMM02864G | Leading Biology | 0.1ml | EUR 528 |
|
Description: A Monoclonal antibody against Human PSMB8. The antibodies are raised in Mouse and are from clone 1A5. This antibody is applicable in WB and IHC, ICC, E |
|||
Mouse PSMB8 shRNA Plasmid |
|||
| 20-abx971337 | Abbexa |
|
|
Rat PSMB8 shRNA Plasmid |
|||
| 20-abx984734 | Abbexa |
|
|
Human PSMB8 shRNA Plasmid |
|||
| 20-abx953843 | Abbexa |
|
|
Canine PSMB8 ELISA KIT |
|||
| ELI-15651d | Lifescience Market | 96 Tests | EUR 928 |
PSMB8 protein (His tag) |
|||
| 80R-2608 | Fitzgerald | 100 ug | EUR 322 |
|
Description: Purified recombinant PSMB8 protein |
|||
PSMB8 Recombinant Protein (Mouse) |
|||
| RP165287 | ABM | 100 ug | Ask for price |
PSMB8 Recombinant Protein (Human) |
|||
| RP085356 | ABM | 100 ug | Ask for price |
PSMB8 Recombinant Protein (Rat) |
|||
| RP222629 | ABM | 100 ug | Ask for price |
Monoclonal PSMB8 Antibody (monoclonal) (M01), Clone: 1B3 |
|||
| AMM03954G | Leading Biology | 0.1mg | EUR 484 |
|
Description: A Monoclonal antibody against Human PSMB8 (monoclonal) (M01). The antibodies are raised in Mouse and are from clone 1B3. This antibody is applicable in WB, IHC and IF, IP, E |
|||
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
| 20-abx114776 | Abbexa |
|
|
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
| 20-abx141396 | Abbexa |
|
|
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
| 20-abx006453 | Abbexa |
|
|
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
| abx011689-100ul | Abbexa | 100 ul | EUR 411 |
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
| abx028154-400ul | Abbexa | 400 ul | EUR 523 |
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
| abx028154-80l | Abbexa | 80 µl | EUR 286 |
Proteasome subunit beta type-8 (PSMB8) Antibody |
|||
| 20-abx211178 | Abbexa |
|
|
Proteasome subunit beta type-8 (PSMB8) Antibody |
|||
| 20-abx211851 | Abbexa |
|
|
[KO Validated] PSMB8 Rabbit pAb |
|||
| A19933-100ul | Abclonal | 100 ul | EUR 410 |
[KO Validated] PSMB8 Rabbit pAb |
|||
| A19933-200ul | Abclonal | 200 ul | EUR 571 |
[KO Validated] PSMB8 Rabbit pAb |
|||
| A19933-20ul | Abclonal | 20 ul | EUR 221 |
[KO Validated] PSMB8 Rabbit pAb |
|||
| A19933-50ul | Abclonal | 50 ul | EUR 287 |
PSMB8 ELISA Kit (Dog) (OKEH03975) |
|||
| OKEH03975 | Aviva Systems Biology | 96 Wells | EUR 844 |
|
Description: Description of target: ;Species reactivity: Dog;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.064 ng/mL |
|||
PSMB8 ELISA Kit (Human) (OKCD02695) |
|||
| OKCD02695 | Aviva Systems Biology | 96 Wells | EUR 792 |
|
Description: Description of target: The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH. The proteasome has an ATP-dependent proteolytic activity. This subunit is involved in antigen processing to generate class I binding peptides. Replacement of PSMB5 by PSMB8 increases the capacity of the immunoproteasome to cleave model peptides after hydrophobic and basic residues. Acts as a major component of interferon gamma-induced sensitivity. Plays a key role in apoptosis via the degradation of the apoptotic inhibitor MCL1. May be involved in the inflammatory response pathway. In cancer cells, substitution of isoform 1 (E2) by isoform 2 (E1) results in immunoproteasome deficiency. Required for the differentiation of preadipocytes into adipocytes.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.117 ng/mL |
|||
PSMB8 ELISA Kit (Human) (OKEH07770) |
|||
| OKEH07770 | Aviva Systems Biology | 96 Wells | EUR 1092 |
|
Description: Description of target: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.06ng/mL |
|||
Psmb8 ORF Vector (Rat) (pORF) |
|||
| ORF074211 | ABM | 1.0 ug DNA | EUR 506 |
PSMB8 ORF Vector (Human) (pORF) |
|||
| ORF028453 | ABM | 1.0 ug DNA | EUR 405 |
Psmb8 ORF Vector (Mouse) (pORF) |
|||
| ORF055097 | ABM | 1.0 ug DNA | EUR 506 |
PSMB8 sgRNA CRISPR Lentivector set (Human) |
|||
| K1740301 | ABM | 3 x 1.0 ug | EUR 339 |
Psmb8 sgRNA CRISPR Lentivector set (Rat) |
|||
| K6921501 | ABM | 3 x 1.0 ug | EUR 339 |
Psmb8 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K4425601 | ABM | 3 x 1.0 ug | EUR 339 |
Human Proteasome subunit beta type-8 (PSMB8) |
|||
| 1-CSB-EP018886HU | Cusabio |
|
|
|
Description: Recombinant Human Proteasome subunit beta type-8(PSMB8) expressed in E.coli |
|||
PSMB8 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K1740302 | ABM | 1.0 ug DNA | EUR 154 |
PSMB8 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K1740303 | ABM | 1.0 ug DNA | EUR 154 |
PSMB8 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K1740304 | ABM | 1.0 ug DNA | EUR 154 |
Psmb8 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
| K6921502 | ABM | 1.0 ug DNA | EUR 154 |
Psmb8 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
| K6921503 | ABM | 1.0 ug DNA | EUR 154 |
Psmb8 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
| K6921504 | ABM | 1.0 ug DNA | EUR 154 |
Psmb8 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K4425602 | ABM | 1.0 ug DNA | EUR 154 |
PSMB8 3'UTR GFP Stable Cell Line |
|||
| TU069046 | ABM | 1.0 ml | EUR 1394 |
Psmb8 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K4425603 | ABM | 1.0 ug DNA | EUR 154 |
Psmb8 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K4425604 | ABM | 1.0 ug DNA | EUR 154 |
PSMB8 Protein Vector (Rat) (pPB-C-His) |
|||
| PV296842 | ABM | 500 ng | EUR 603 |
PSMB8 Protein Vector (Rat) (pPB-N-His) |
|||
| PV296843 | ABM | 500 ng | EUR 603 |
A novel carbon nanoparticle probe-based ultrasensitive lateral circulation assay for quick detection of Ebola virus.
Ebola virus (EBOV) is an terribly contagious pathogen first present in Africa associated to excessive hemorrhagic sickness in individuals and nonhuman primates, which has resulted in at least 28 500 suspected circumstances and 11 300 confirmed deaths in 2014-2016 Ebola epidemic in West Africa.
Speedy and delicate detection of EBOV is the essential factor to rising the likelihood of survival and reducing an an infection costs in pandemic areas. Proper right here, we report an ultrasensitive and instrument-free EBOV detection assay primarily based totally on colloidal carbon immunochromatography.
Carbon nanoparticle-labeled rabbit anti-EBOV-VP40 IgG had been concentrated inside the conjugate pad, monoclonal antibody (McAb, 4B7F9) in the direction of EBOV-VP40 and goat anti-rabbit IgG had been immobilized on the nitrocellulose membrane with 2 μL/cm at a spotlight of 1 mg/mL as check out and administration strains, respectively.
Then the sample software program pad, conjugate launch pad, nitrocellulose membrane and absorbent pad had been assembled proper right into a lateral circulation check out strip.
The check out strip reveals strong specificity in the direction of related viruses that share comparable medical indicators and geographic fluctuate with EBOV, along with marburg virus, influenza virus, yellow fever virus and dengue virus. In addition to, 1 500 damaging serums had been examined with false-positive value of 1.3‰ which significantly lower than that of ReEBOV™ colloidal gold check out bundle helpful by World Nicely being Group (WHO).
The sensitivity of this strip was analyzed using inactivated EBOV with detection prohibit of 100 ng/mL (10⁶ copies/mL) which clearly elevated than that of ReEBOV™ dipstick (10⁸ copies/mL). Furthermore, the strip confirmed wonderful thermal stability traits in room temperature and is likely to be as a point-of-care (POC), ultra-sensitive and specific promising candidate for EBOV serological screening in rural Africa or entry/exit ports.
A Survey of Virus Recombination Uncovers Canonical Choices of Artificial Chimeras Generated All through Deep Sequencing Library Preparation.
Chimeric reads could also be generated by in vitro recombination all through the preparation of high-throughput sequencing libraries.
Our attempt to detect natural recombination between the genomes of dengue virus (DENV; +ssRNA genome) and its mosquito host using the Illumina Nextera sequencing library preparation bundle revealed that almost all, if not all, detected host-virus chimeras had been artificial.
Definitely, these chimeras weren’t further frequent than with administration RNA from one different species (a pillbug), which was certainly not in contact with DENV RNA earlier to the library preparation.
The proportion of chimera varieties merely mirrored these of the three species amongst sequencing reads. Chimeras had been repeatedly characterised by the presence of 1-20 bp microhomology between recombining fragments.
Inside-species chimeras principally involved fragments in reverse orientations and located decrease than 100 bp from each other inside the parental genome.
We found comparable choices in printed datasets using two totally different viruses: Ebola virus (EBOV; -ssRNA genome) and a herpesvirus (dsDNA genome), every produced with the Illumina Nextera protocol. These canonical choices counsel that artificial chimeras are generated by intra-molecular template switching of the DNA polymerase all through the PCR step of the Nextera protocol.
Lastly, a broadcast Illumina dataset using the Flock Residence virus (FHV; +ssRNA genome) generated with a protocol stopping artificial recombination revealed the presence of 1-10 bp microhomology motifs in FHV-FHV chimeras, nonetheless just a few recombining fragments had been in reverse orientations.
Our analysis uncovered sequence choices characterizing recombination breakpoints in short-read sequencing datasets, which can be helpful to guage the presence and extent of artificial recombination.
Influenza A Virus H3N2 Brisbane 10 / 07 Protein |
|||
| 20-abx260509 | Abbexa |
|
|
Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen |
|||
| 11-567 | ProSci | 0.1 mg | EUR 527 |
|
Description: Influenza A (A/Brisbane/10/07), Influenza A Virus, Strain A/Brisbane/10/07 (H3N2) |
|||
Rabbit Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG, aff pure |
|||
| H3N23-A | Alpha Diagnostics | 100 ul | EUR 445 |
Influenza A H3 Antibody |
|||
| abx021977-1mg | Abbexa | 1 mg | EUR 878 |
Influenza A H3 Antibody |
|||
| abx021978-1mg | Abbexa | 1 mg | EUR 878 |
Lung Tissue Lysate (Tumor) |
|||
| 1703-07 | ProSci | 0.1 mg | EUR 280.25 |
|
Description: Lung tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
Kidney Tissue Lysate (Tumor) |
|||
| 1707-07 | ProSci | 0.1 mg | EUR 280.25 |
|
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
Breast Tissue Lysate (Normal) |
|||
| 1710-07 | ProSci | 0.1 mg | EUR 217.25 |
|
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
Breast Tissue Lysate (Tumor) |
|||
| 1714-07 | ProSci | 0.1 mg | EUR 280.25 |
|
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
Colon Tissue Lysate (Normal) |
|||
| 1715-07 | ProSci | 0.1 mg | EUR 217.25 |
|
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
|||
| 11-563 | ProSci | 0.05 mg | EUR 527 |
|
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
|||
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
|||
| 11-564 | ProSci | 0.05 mg | EUR 527 |
|
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
|||
Influenza A antibody |
|||
| 10-1096 | Fitzgerald | 500 ug | EUR 208 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1097 | Fitzgerald | 1 mg | EUR 349 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1098 | Fitzgerald | 1 mg | EUR 605 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1099 | Fitzgerald | 1 mg | EUR 605 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1100 | Fitzgerald | 500 ug | EUR 349 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1101 | Fitzgerald | 1 mg | EUR 605 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1102 | Fitzgerald | 500 ug | EUR 349 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1103 | Fitzgerald | 500 ug | EUR 349 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1241 | Fitzgerald | 500 ug | EUR 349 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1243 | Fitzgerald | 500 ug | EUR 349 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-7866 | Fitzgerald | 1 mg | EUR 403 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-7867 | Fitzgerald | 1 mg | EUR 403 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50A | Fitzgerald | 1 mg | EUR 503 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50B | Fitzgerald | 1 mg | EUR 392 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50C | Fitzgerald | 1 mg | EUR 392 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50D | Fitzgerald | 1 mg | EUR 279 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50E | Fitzgerald | 1 mg | EUR 279 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50F | Fitzgerald | 1 mg | EUR 273 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50G | Fitzgerald | 1 mg | EUR 408 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50H | Fitzgerald | 1 mg | EUR 541 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50I | Fitzgerald | 1 mg | EUR 408 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50K | Fitzgerald | 1 mg | EUR 273 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50L | Fitzgerald | 1 mg | EUR 300 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50M | Fitzgerald | 1 mg | EUR 300 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50N | Fitzgerald | 1 mg | EUR 300 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50O | Fitzgerald | 1 mg | EUR 300 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50P | Fitzgerald | 1 mg | EUR 300 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50Q | Fitzgerald | 1 mg | EUR 273 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50R | Fitzgerald | 1 mg | EUR 273 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50S | Fitzgerald | 1 mg | EUR 273 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50T | Fitzgerald | 1 mg | EUR 273 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50U | Fitzgerald | 1 mg | EUR 273 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A virus H3 PCR kit |
|||
| PCR-H649-48R | Bioingentech | 50T | EUR 823 |
Influenza A virus H3 PCR kit |
|||
| PCR-H649-96R | Bioingentech | 100T | EUR 1113 |
Influenza A Virus H3 Antigen Antibody |
|||
| abx415738-01mg | Abbexa | 0.1 mg | EUR 718 |
Influenza A virus fragment |
|||
| A1075-10 | ApexBio | 10 mg | EUR 282 |
|
Description: Influenza A virus fragment has the RNA sequence of Leu-Lys-Phe-Ala-Phe-Ser-Met-Met.Influenzavirus A is agenusof the Orthomyxoviridaefamily of viruses. |
|||
IAV H3N2 nucleoprotein (A/Brisbane/10/2007) [His] |
|||
| DAG2329 | Creative Diagnostics | 100 µg | EUR 724 |
Influenza B Virus Florida 07/04 |
|||
| 7-07918 | CHI Scientific | 10µg | Ask for price |
Influenza B Virus Florida 07/04 |
|||
| 7-07919 | CHI Scientific | 50µg | Ask for price |
Influenza B Virus Florida 07/04 |
|||
| 7-07920 | CHI Scientific | 1mg | Ask for price |
Mouse Monoclonal Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG |
|||
| H3N21-M | Alpha Diagnostics | 100 ul | EUR 482 |
Influenza A virus H3 RT PCR kit |
|||
| RTq-H649-100R | Bioingentech | 100T | EUR 1311 |
Influenza A virus H3 RT PCR kit |
|||
| RTq-H649-150R | Bioingentech | 150T | EUR 1787 |
Influenza A virus H3 RT PCR kit |
|||
| RTq-H649-50R | Bioingentech | 50T | EUR 963 |
Influenza A HA H1 antibody |
|||
| 10-7839 | Fitzgerald | 500 ug | EUR 291 |
|
Description: Mouse monoclonal Influenza A haemagglutinin H1 antibody |
|||
Influenza A HA H1 antibody |
|||
| 10-7840 | Fitzgerald | 500 ug | EUR 291 |
|
Description: Mouse monoclonal Influenza A haemagglutinin H1 antibody |
|||
Influenza A HA H5 antibody |
|||
| 10-7854 | Fitzgerald | 1 mg | EUR 732 |
|
Description: Mouse monoclonal Influenza A HA H5 antibody |
|||
Influenza A HA H5 antibody |
|||
| 10-7855 | Fitzgerald | 1 mg | EUR 732 |
|
Description: Mouse monoclonal Influenza A HA H5 antibody |
|||
Influenza A HA H5 antibody |
|||
| 10-7856 | Fitzgerald | 1 mg | EUR 732 |
|
Description: Mouse monoclonal Influenza A HA H5 antibody |
|||
Influenza B (B / Florida / 07 / 04) Protein |
|||
| abx060630-1mg | Abbexa | 1 mg | EUR 1873 |
Influenza B Virus Florida 07 / 04 Protein |
|||
| 20-abx260511 | Abbexa |
|
|
Influenza A virus H3 One-Step PCR kit |
|||
| Oneq-H649-100R | Bioingentech | 100T | EUR 1610 |
Influenza A virus H3 One-Step PCR kit |
|||
| Oneq-H649-150R | Bioingentech | 150T | EUR 2205 |
Influenza A virus H3 One-Step PCR kit |
|||
| Oneq-H649-50R | Bioingentech | 50T | EUR 1175 |
IAV H3N2 H3 (aa 17-529) (A/Panama/07/99) [His] |
|||
| DAG2162 | Creative Diagnostics | 100 µg | Ask for price |
hemagglutinin (332-340) [Influenza A virus] |
|||
| A1141-10 | ApexBio | 10 mg | EUR 340 |
|
Description: Influenza hemagglutinin (HA) is a type of hemagglutinin found on the surface of the influenza viruses. It is an antigenic glycoprotein. It is responsible for binding the virus to the cell that is being infected. |
|||
IAV H3N2 (aa 18-530) (A/Brisbane/10/2007) [His] |
|||
| DAG1693 | Creative Diagnostics | 50 ug | EUR 1681 |
IAV H3N2 non-structural 1 (A/Brisbane/10/2007 ) [His] |
|||
| DAG2335 | Creative Diagnostics | 100 µg | EUR 724 |
Recombinant (HEK) Influenza A HA1 protein (A/California/07/2009 (H1N1; 18-345 aa,55-60 kda, >95%, his-tag) |
|||
| H1N1-02-R-10 | Alpha Diagnostics | 10 ug | EUR 286 |
Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-10ug |
|||
| QP12081-10ug | EnQuireBio | 10ug | EUR 155 |
Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-1mg |
|||
| QP12081-1mg | EnQuireBio | 1mg | EUR 2059 |
Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-50ug |
|||
| QP12081-50ug | EnQuireBio | 50ug | EUR 201 |
Influenza B Strain B/Florida/07/04 Antigen |
|||
| 11-575 | ProSci | 0.1 mg | EUR 527 |
|
Description: Influenza B (B/Florida/07/04), Influenza B Virus, Strain B/Florida/07/04 |
|||
Anti-07/02/07 |
|||
| STJ501223 | St John's Laboratory | 100 µg | EUR 476 |
NATtrol Influenza A H3 Virus Stock (Qualitative) (1 mL) |
|||
| NATFLUAH3-ST | Zeptometrix | 1 mL | EUR 1137.84 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
IAV H3N2 Hemagglutinin (aa 17-530) (A/Brisbane/10/2007) [His] |
|||
| DAG2224 | Creative Diagnostics | 100 µg | EUR 913 |
IAV H1N1 nucleoprotein (aa 1-486) (A/Brisbane/10/2007) [His] |
|||
| DAG2328 | Creative Diagnostics | 100 µg | EUR 724 |
Recombinant (HEK) Influenza A H1N1 HA protein (A/California/07/2009 (H1N1), ?TM 18-529 aa, 70-75 kda, >95%, his-tag) |
|||
| H1N1-03-R-10 | Alpha Diagnostics | 10 ug | EUR 286 |
[bAla8]-Neurokinin A(4-10) |
|||
| B6813-10 | ApexBio | 10 mg | EUR 1479 |
A-20 Lysate |
|||
| 1288 | ProSci | 0.1 mg | EUR 191 |
|
Description: A-20 lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The A-20 lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
hemagglutinin precursor (114-122) amide [Influenza A virus] |
|||
| A1142-10 | ApexBio | 10 mg | EUR 340 |
|
Description: hemagglutinin precursor(114-122) amide [Influenza A virus] |
|||
IAV H3N2 Hemagglutinin 1 (aa 17-345) (A/Brisbane/10/2007) [His] |
|||
| DAG2282 | Creative Diagnostics | 100 µg | EUR 913 |
Influenza A antibody |
|||
| 10R-I131a | Fitzgerald | 1 mg | EUR 476 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10R-I131b | Fitzgerald | 1 mg | EUR 489 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10C-CR1306M1 | Fitzgerald | 100 ug | EUR 506 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10C-CR1306M2 | Fitzgerald | 100 ug | EUR 281 |
|
Description: Mouse monoclonal Influenza A antibody |
|||